Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1501 participants
OBSERVATIONAL
2014-10-31
2016-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions in Small Vessels
NCT01498692
The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions
NCT00823212
Prospective, Randomized, Multicenter Trial to Assess PROMUS™ Element™ Stent
NCT01285999
The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of Long De Novo Coronary Artery Lesions (PLATINUM LL)
NCT01500434
NG PROMUS Stent System for the Treatment of Atherosclerotic Coronary Lesions
NCT01703000
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
PLATINUM Diversity (Overall)
PLATINUM Diversity (Overall) population. Test device is Promus PREMIER Everolimus-Eluting Platinum Chromium Coronary Stent System (CSS)
Percutaneous coronary intervention (Promus PREMIER)
Interventional coronary artery stenting with Promus PREMIER study stent.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Percutaneous coronary intervention (Promus PREMIER)
Interventional coronary artery stenting with Promus PREMIER study stent.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient must sign informed consent form
* Patient has received at least one Promus PREMIER stent
* Patient self-identifies as one or more of the following:
* Female
* Black of African Heritage
* Hispanic/Latino
* American Indian or Alaska native
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Boston Scientific Corporation
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Roxana Mehran, MD
Role: PRINCIPAL_INVESTIGATOR
Icahn School of Medicine at Mount Sinai
Wayne Batchelor, MD
Role: PRINCIPAL_INVESTIGATOR
Tallahassee Memorial Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
St Luke's Medical Center
Phoenix, Arizona, United States
St Bernards Heart and Vascular
Jonesboro, Arkansas, United States
Arkansas Cardiology/Baptist Health Medical Center
Little Rock, Arkansas, United States
Central Cardiology Medical Clinic
Bakersfield, California, United States
Sharp Chula Vista Medical Center
Chula Vista, California, United States
Cardiovascular Consultants Heart Center
Fresno, California, United States
UCLA Medical Center
Los Angeles, California, United States
Mercy General Hospital
Sacramento, California, United States
Capital Research Institute
Washington D.C., District of Columbia, United States
Bay Area Cardiology
Brandon, Florida, United States
Research Physicians Network Alliance
Hollywood, Florida, United States
Memorial Hospital Jacksonville
Jacksonville, Florida, United States
Cardiovascular Institute of Northwest Florida
Panama City, Florida, United States
Charlotte Heart & Vascular
Port Charlotte, Florida, United States
Tallahassee Memorial Hospital
Tallahassee, Florida, United States
Pepin Heart Hospital and Dr. Kiran C. Patel Research Institute
Tampa, Florida, United States
Emory University
Atlanta, Georgia, United States
University Hospital
Augusta, Georgia, United States
Redmond Regional Medical Center
Rome, Georgia, United States
University of Chicago Medical Center
Chicago, Illinois, United States
Presence Saint Joseph Medical Center
Joliet, Illinois, United States
The Heart Center of Lake County
Merrillville, Indiana, United States
University of Iowa Hospitals and Clinics
Iowa City, Iowa, United States
Cardiovascular Research, LLC (Willis-Knighton)
Shreveport, Louisiana, United States
MedStar Union Memorial Hospital
Baltimore, Maryland, United States
Suburban Hospital
Bethesda, Maryland, United States
Delmarva Heart Research Foundation
Salisbury, Maryland, United States
Baystate Medical Center
Springfield, Massachusetts, United States
CCA Research
Gulfport, Mississippi, United States
North Kansas City Hospital
North Kansas City, Missouri, United States
St. Louis Heart and Vascular
St Louis, Missouri, United States
Jersey Shore University Medical Center
Neptune City, New Jersey, United States
Mount Sinai Hospital
New York, New York, United States
Montefiore Medical Center
The Bronx, New York, United States
Novant Health Heart and Vascular Institute
Charlotte, North Carolina, United States
NC Heart and Vascular Research
Raleigh, North Carolina, United States
INTEGRIS Baptist Medical Center
Oklahoma City, Oklahoma, United States
Presbyterian University Hospital
Pittsburgh, Pennsylvania, United States
Lankenau Medical Center
Wynnewood, Pennsylvania, United States
Palmetto Health
Columbia, South Carolina, United States
St. Francis Physician Services Inc., DBA Upstate Cardiology
Greenville, South Carolina, United States
Seton Heart Institute
Austin, Texas, United States
Methodist Hospital Dallas
Dallas, Texas, United States
VA North Texas Health Care System
Dallas, Texas, United States
Plaza Medical Center of Forth Worth
Fort Worth, Texas, United States
University of Texas Medical Branch at Galveston
Galveston, Texas, United States
St. Luke's Episcopal Hospital
Houston, Texas, United States
Christus Santa Rosa Hospital-City Center
New Braunfels, Texas, United States
The University of Vermont Medical Center
Burlington, Vermont, United States
Virginia Mason
Seattle, Washington, United States
Cardiac Study Center
Tacoma, Washington, United States
CAMC Clinical Trials Center
Charleston, West Virginia, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Batchelor W, Kandzari DE, Davis S, Tami L, Wang JC, Othman I, Gigliotti OS, Haghighat A, Singh S, Lopez M, Giugliano G, Horwitz PA, Chandrasekhar J, Underwood P, Thompson CA, Mehran R. Outcomes in Women and Minorities Compared With White Men 1 Year After Everolimus-Eluting Stent Implantation: Insights and Results From the PLATINUM Diversity and PROMUS Element Plus Post-Approval Study Pooled Analysis. JAMA Cardiol. 2017 Dec 1;2(12):1303-1313. doi: 10.1001/jamacardio.2017.3802.
Epps K, Goel R, Mehran R, Kandzari D, Damluji A, Tehrani B, Sherwood M, Truesdell A, Davis S, Wang JC, Lopez M, Singh S, Underwood P, Allocco D, Batchelor W. Influence of Race/Ethnicity and Sex on Coronary Stent Outcomes in Diabetic Patients. J Soc Cardiovasc Angiogr Interv. 2023 Sep-Oct;2(5):101053. doi: 10.1016/j.jscai.2023.101053. Epub 2023 Aug 4.
Beerkens FJ, Cao D, Batchelor W, Sartori S, Kandzari DE, Davis S, Tamis L, Wang JC, Othman I, Vogel B, Spirito A, Subramaniam V, Gigliotti OS, Haghighat A, Feng Y, Singh S, Lopez M, Giugliano G, Horwitz PA, Dangas G, Mehran R. Percutaneous Coronary Intervention in Men, Women, and Minorities With a Previous Coronary Artery Bypass Graft Surgery (from the Pooled PLATINUM Diversity and PROMUS Element Plus Registries). Am J Cardiol. 2023 Aug 1;200:204-211. doi: 10.1016/j.amjcard.2023.05.028. Epub 2023 Jun 22.
Batchelor WB, Damluji AA, Yong C, Fiuzat M, Barnett SD, Kandzari DE, Sherwood MW, Epps KC, Tehrani BN, Allocco DJ, Meredith IT, Lindenfeld J, O'Connor CM, Mehran R. Does study subject diversity influence cardiology research site performance?: Insights from 2 U.S. National Coronary Stent Registries. Am Heart J. 2021 Jun;236:37-48. doi: 10.1016/j.ahj.2021.02.003. Epub 2021 Feb 24.
Mehran R, Chandrasekhar J, Davis S, Nathan S, Hill R, Hearne S, Vismara V, Pyo R, Gharib E, Hawa Z, Chrysant G, Kandzari D, Underwood P, Allocco DJ, Batchelor W. Impact of Race and Ethnicity on the Clinical and Angiographic Characteristics, Social Determinants of Health, and 1-Year Outcomes After Everolimus-Eluting Coronary Stent Procedures in Women. Circ Cardiovasc Interv. 2019 Apr;12(4):e006918. doi: 10.1161/CIRCINTERVENTIONS.118.006918.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
S2326
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.